Securities Class Action
No Litigation found for Xeris Biopharma Holdings, Inc.
Material Events
Critical Governance & Disclosure
3
Board, Voting & Shareholder Rights
6
Capital Structure & Financial Risk
1
Disclosure & Communications
22
SEC Filings
Insider Transaction
Transactions
4
Insider Involved
3
Total Buys
$0.00
Total Sells
$772.7K